NCT06505967

Effectiveness of Qualia NAD+ Supplementation on Intracellular NAD Levels

Effectiveness of Qualia NAD+ Supplementation on Intracellular NAD Levels: A Randomized Double-Blind Parallel Trial

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 200 (estimated)
• Sponsor: Qualia Life Sciences · Industry
• Sex: All
• Age: 40 Years – 65 Years
• Healthy volunteers: Accepted

Summary

The goal of this clinical trial is to determine if Qualia NAD+ effectively increases NAD+ levels in the blood and to evaluate its safety. Researchers will compare Qualia NAD+ to a placebo (a look-alike substance that contains no active drug) to assess its efficacy in increasing NAD+ levels in the blood. Participants will: Take Qualia NAD+ or a placebo every day for 4 weeks. Undergo blood tests before and after the trial.

Conditions

• NAD+ Levels in the Blood

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Qualia NAD+	Qualia NAD+ is a novel dietary supplement, formulated to support the maintenance and enhancement of intracellular NAD levels.
OTHER	Placebo	Rice flour

Timeline

• Start date: 2024-06-10
• Primary completion: 2024-08-18
• Completion: 2024-09-09
• First posted: 2024-07-17
• Last updated: 2024-07-17

Locations

1 site across 1 country: United States